Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

19.77

+0.18 (0.92%)

At close: Sep 3, 2025, 4:00 PM

19.77

0.00 (0.00%)

After-hours: Sep 3, 2025, 4:10 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M	Log In
Antisense Oligonucleotide Growth	-29.22%	Log In

Revenue by Geography

Fiscal year is January - December.